ScholarIQanswers from OpenAlex
Donanemab in Early Symptomatic Alzheimer Disease
PaperCitations, authors & open-access status
Donanemab in Early Symptomatic Alzheimer Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Donanemab in Early Symptomatic Alzheimer Disease have?
ScholarIQcitation count
Donanemab in Early Symptomatic Alzheimer Disease has 2,694 citations in the OpenAlex counts ScholarIQ stores.
When was Donanemab in Early Symptomatic Alzheimer Disease published?
ScholarIQyear
Donanemab in Early Symptomatic Alzheimer Disease has 2023 year in the ScholarIQ index.
What is the open-access status of Donanemab in Early Symptomatic Alzheimer Disease?
ScholarIQoa status
Donanemab in Early Symptomatic Alzheimer Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Donanemab in Early Symptomatic Alzheimer Disease?
ScholarIQdoi
The DOI for Donanemab in Early Symptomatic Alzheimer Disease is on the source record.
What is the PMID of Donanemab in Early Symptomatic Alzheimer Disease?
ScholarIQpmid
The PMID for Donanemab in Early Symptomatic Alzheimer Disease is on the source record.
What is the OpenAlex record for Donanemab in Early Symptomatic Alzheimer Disease?
ScholarIQopenalex
The OpenAlex for Donanemab in Early Symptomatic Alzheimer Disease is on the source record.